Therapeutic targeting of α7 nicotinic acetylcholine receptors

RL Papke, NA Horenstein, H Khoshbouei - Pharmacological Reviews, 2021 - Elsevier
The α7-type nicotinic acetylcholine receptor is one of the most unique and interesting of all
the members of the cys-loop superfamily of ligand-gated ion channels. Since it was first …

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

LF Martin, WR Kem, R Freedman - Psychopharmacology, 2004 - Springer
Rationale and objective Auditory sensory gating, a biological measurement of the ability to
suppress the evoked response to the second of two auditory stimuli, is diminished in people …

An inhibitory brainstem input to dopamine neurons encodes nicotine aversion

C Liu, AJ Tose, JPH Verharen, Y Zhu, LW Tang… - Neuron, 2022 - cell.com
Nicotine stimulates the dopamine (DA) system, which is essential for its rewarding effect.
Nicotine is also aversive at high doses; yet, our knowledge about nicotine's dose-dependent …

The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: physiopathological implications

C Hilmas, EFR Pereira, M Alkondon… - Journal of …, 2001 - Soc Neuroscience
The tryptophan metabolite kynurenic acid (KYNA) has long been recognized as an NMDA
receptor antagonist. Here, interactions between KYNA and the nicotinic system in the brain …

[HTML][HTML] Nicotinic acetylcholine receptors and epilepsy

A Becchetti, LC Grandi, M Cerina, A Amadeo - Pharmacological Research, 2023 - Elsevier
Despite recent advances in understanding the causes of epilepsy, especially the genetic,
comprehending the biological mechanisms that lead to the epileptic phenotype remains …

The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum

SR Grady, O Salminen, DC Laverty, P Whiteaker… - Biochemical …, 2007 - Elsevier
This review summarizes studies that attempted to determine the subtypes of nicotinic
acetylcholine receptors (nAChR) expressed in the dopaminergic nerve terminals in the …

SSR180711, a novel selective α7 nicotinic receptor partial agonist:(II) efficacy in experimental models predictive of activity against cognitive symptoms of …

P Pichat, OE Bergis, JP Terranova, A Urani… - …, 2007 - nature.com
Abstract SSR180711 (4-bromophenyl 1, 4diazabicyclo (3.2. 2) nonane-4-carboxylate,
monohydrochloride) is a selective α7 nicotinic receptor (n-AChR) partial agonist. Based on …

Interictal spikes during sleep are an early defect in the Tg2576 mouse model of β-amyloid neuropathology

K Kam, ÁM Duffy, J Moretto, JJ LaFrancois… - Scientific reports, 2016 - nature.com
It has been suggested that neuronal hyperexcitability contributes to Alzheimer's disease
(AD), so we asked how hyperexcitability develops in a common mouse model of β-amyloid …

Nicotine improves sustained attention in mice: evidence for involvement of the α7 nicotinic acetylcholine receptor

JW Young, K Finlayson, C Spratt, HM Marston… - …, 2004 - nature.com
In humans, nicotine has been shown to improve attention in both normal and impaired
individuals. Observations in rats reflect some, but not all aspects of the nicotine-induced …

The β2 but not α7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice

CL Walters, S Brown, JP Changeux, B Martin… - …, 2006 - Springer
Rationale Tobacco use is implicated in approximately 440,000 deaths per year, making it
the leading cause of preventable death in the United States. Although it is generally …